Serotonin 2A receptors and visual hallucinations in Parkinson disease.
Identifieur interne : 001993 ( Main/Exploration ); précédent : 001992; suivant : 001994Serotonin 2A receptors and visual hallucinations in Parkinson disease.
Auteurs : Benedicte Ballanger [Canada] ; Antonio P. Strafella ; Thilo Van Eimeren ; Mateusz Zurowski ; Pablo M. Rusjan ; Sylvain Houle ; Susan H. FoxSource :
- Archives of neurology [ 1538-3687 ] ; 2010.
English descriptors
- KwdEn :
- Aged, Brain (diagnostic imaging), Brain (metabolism), Brain (physiopathology), Brain Mapping, Case-Control Studies, Female, Hallucinations (diagnostic imaging), Hallucinations (etiology), Hallucinations (physiopathology), Humans, Male, Middle Aged, Parkinson Disease (complications), Parkinson Disease (diagnostic imaging), Parkinson Disease (physiopathology), Pilot Projects, Positron-Emission Tomography, Pyrimidinones, Receptor, Serotonin, 5-HT2A (genetics), Receptor, Serotonin, 5-HT2A (metabolism), Serotonin (metabolism), Serotonin Antagonists, Temporal Lobe (diagnostic imaging), Temporal Lobe (metabolism), Temporal Lobe (physiopathology), Visual Cortex (diagnostic imaging), Visual Cortex (metabolism), Visual Cortex (physiopathology), Visual Pathways (diagnostic imaging), Visual Pathways (metabolism), Visual Pathways (physiopathology).
- MESH :
- chemical , genetics : Receptor, Serotonin, 5-HT2A.
- chemical , metabolism : Receptor, Serotonin, 5-HT2A, Serotonin.
- chemical : Pyrimidinones, Serotonin Antagonists.
- complications : Parkinson Disease.
- diagnostic imaging : Brain, Hallucinations, Parkinson Disease, Temporal Lobe, Visual Cortex, Visual Pathways.
- etiology : Hallucinations.
- metabolism : Brain, Temporal Lobe, Visual Cortex, Visual Pathways.
- physiopathology : Brain, Hallucinations, Parkinson Disease, Temporal Lobe, Visual Cortex, Visual Pathways.
- Aged, Brain Mapping, Case-Control Studies, Female, Humans, Male, Middle Aged, Pilot Projects, Positron-Emission Tomography.
Abstract
Complex visual hallucinations (VHs) occur in several pathologic conditions; however, the neural mechanisms underlying these symptoms remain unclear. Although dopamine may have a role, indirect evidence indicates that serotonin may also contribute to the pathogenesis of complex VHs, probably via involvement of the serotonin 2 receptor.
DOI: 10.1001/archneurol.2010.35
PubMed: 20385906
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000D63
- to stream PubMed, to step Curation: 000D63
- to stream PubMed, to step Checkpoint: 000D63
- to stream Ncbi, to step Merge: 000C48
- to stream Ncbi, to step Curation: 000C48
- to stream Ncbi, to step Checkpoint: 000C48
- to stream Main, to step Merge: 001A99
- to stream Main, to step Curation: 001993
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Serotonin 2A receptors and visual hallucinations in Parkinson disease.</title><author><name sortKey="Ballanger, Benedicte" sort="Ballanger, Benedicte" uniqKey="Ballanger B" first="Benedicte" last="Ballanger">Benedicte Ballanger</name><affiliation wicri:level="1"><nlm:affiliation>Vivian M. Rakoff PET Centre, Toronto Western Hospital, Toronto, Ontario, Canada</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Vivian M. Rakoff PET Centre, Toronto Western Hospital, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P" last="Strafella">Antonio P. Strafella</name></author><author><name sortKey="Van Eimeren, Thilo" sort="Van Eimeren, Thilo" uniqKey="Van Eimeren T" first="Thilo" last="Van Eimeren">Thilo Van Eimeren</name></author><author><name sortKey="Zurowski, Mateusz" sort="Zurowski, Mateusz" uniqKey="Zurowski M" first="Mateusz" last="Zurowski">Mateusz Zurowski</name></author><author><name sortKey="Rusjan, Pablo M" sort="Rusjan, Pablo M" uniqKey="Rusjan P" first="Pablo M" last="Rusjan">Pablo M. Rusjan</name></author><author><name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name></author><author><name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H" last="Fox">Susan H. Fox</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:20385906</idno><idno type="pmid">20385906</idno><idno type="doi">10.1001/archneurol.2010.35</idno><idno type="wicri:Area/PubMed/Corpus">000D63</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000D63</idno><idno type="wicri:Area/PubMed/Curation">000D63</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000D63</idno><idno type="wicri:Area/PubMed/Checkpoint">000D63</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000D63</idno><idno type="wicri:Area/Ncbi/Merge">000C48</idno><idno type="wicri:Area/Ncbi/Curation">000C48</idno><idno type="wicri:Area/Ncbi/Checkpoint">000C48</idno><idno type="wicri:Area/Main/Merge">001A99</idno><idno type="wicri:Area/Main/Curation">001993</idno><idno type="wicri:Area/Main/Exploration">001993</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Serotonin 2A receptors and visual hallucinations in Parkinson disease.</title><author><name sortKey="Ballanger, Benedicte" sort="Ballanger, Benedicte" uniqKey="Ballanger B" first="Benedicte" last="Ballanger">Benedicte Ballanger</name><affiliation wicri:level="1"><nlm:affiliation>Vivian M. Rakoff PET Centre, Toronto Western Hospital, Toronto, Ontario, Canada</nlm:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Vivian M. Rakoff PET Centre, Toronto Western Hospital, Toronto, Ontario</wicri:regionArea><wicri:noRegion>Ontario</wicri:noRegion></affiliation></author><author><name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P" last="Strafella">Antonio P. Strafella</name></author><author><name sortKey="Van Eimeren, Thilo" sort="Van Eimeren, Thilo" uniqKey="Van Eimeren T" first="Thilo" last="Van Eimeren">Thilo Van Eimeren</name></author><author><name sortKey="Zurowski, Mateusz" sort="Zurowski, Mateusz" uniqKey="Zurowski M" first="Mateusz" last="Zurowski">Mateusz Zurowski</name></author><author><name sortKey="Rusjan, Pablo M" sort="Rusjan, Pablo M" uniqKey="Rusjan P" first="Pablo M" last="Rusjan">Pablo M. Rusjan</name></author><author><name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name></author><author><name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H" last="Fox">Susan H. Fox</name></author></analytic><series><title level="j">Archives of neurology</title><idno type="eISSN">1538-3687</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Brain (diagnostic imaging)</term><term>Brain (metabolism)</term><term>Brain (physiopathology)</term><term>Brain Mapping</term><term>Case-Control Studies</term><term>Female</term><term>Hallucinations (diagnostic imaging)</term><term>Hallucinations (etiology)</term><term>Hallucinations (physiopathology)</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (complications)</term><term>Parkinson Disease (diagnostic imaging)</term><term>Parkinson Disease (physiopathology)</term><term>Pilot Projects</term><term>Positron-Emission Tomography</term><term>Pyrimidinones</term><term>Receptor, Serotonin, 5-HT2A (genetics)</term><term>Receptor, Serotonin, 5-HT2A (metabolism)</term><term>Serotonin (metabolism)</term><term>Serotonin Antagonists</term><term>Temporal Lobe (diagnostic imaging)</term><term>Temporal Lobe (metabolism)</term><term>Temporal Lobe (physiopathology)</term><term>Visual Cortex (diagnostic imaging)</term><term>Visual Cortex (metabolism)</term><term>Visual Cortex (physiopathology)</term><term>Visual Pathways (diagnostic imaging)</term><term>Visual Pathways (metabolism)</term><term>Visual Pathways (physiopathology)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Receptor, Serotonin, 5-HT2A</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Receptor, Serotonin, 5-HT2A</term><term>Serotonin</term></keywords><keywords scheme="MESH" type="chemical" xml:lang="en"><term>Pyrimidinones</term><term>Serotonin Antagonists</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Brain</term><term>Hallucinations</term><term>Parkinson Disease</term><term>Temporal Lobe</term><term>Visual Cortex</term><term>Visual Pathways</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Hallucinations</term></keywords><keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Brain</term><term>Temporal Lobe</term><term>Visual Cortex</term><term>Visual Pathways</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Brain</term><term>Hallucinations</term><term>Parkinson Disease</term><term>Temporal Lobe</term><term>Visual Cortex</term><term>Visual Pathways</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Brain Mapping</term><term>Case-Control Studies</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Pilot Projects</term><term>Positron-Emission Tomography</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Complex visual hallucinations (VHs) occur in several pathologic conditions; however, the neural mechanisms underlying these symptoms remain unclear. Although dopamine may have a role, indirect evidence indicates that serotonin may also contribute to the pathogenesis of complex VHs, probably via involvement of the serotonin 2 receptor.</div></front></TEI><affiliations><list><country><li>Canada</li></country></list><tree><noCountry><name sortKey="Fox, Susan H" sort="Fox, Susan H" uniqKey="Fox S" first="Susan H" last="Fox">Susan H. Fox</name><name sortKey="Houle, Sylvain" sort="Houle, Sylvain" uniqKey="Houle S" first="Sylvain" last="Houle">Sylvain Houle</name><name sortKey="Rusjan, Pablo M" sort="Rusjan, Pablo M" uniqKey="Rusjan P" first="Pablo M" last="Rusjan">Pablo M. Rusjan</name><name sortKey="Strafella, Antonio P" sort="Strafella, Antonio P" uniqKey="Strafella A" first="Antonio P" last="Strafella">Antonio P. Strafella</name><name sortKey="Van Eimeren, Thilo" sort="Van Eimeren, Thilo" uniqKey="Van Eimeren T" first="Thilo" last="Van Eimeren">Thilo Van Eimeren</name><name sortKey="Zurowski, Mateusz" sort="Zurowski, Mateusz" uniqKey="Zurowski M" first="Mateusz" last="Zurowski">Mateusz Zurowski</name></noCountry><country name="Canada"><noRegion><name sortKey="Ballanger, Benedicte" sort="Ballanger, Benedicte" uniqKey="Ballanger B" first="Benedicte" last="Ballanger">Benedicte Ballanger</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001993 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001993 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Canada
|area= ParkinsonCanadaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:20385906
|texte= Serotonin 2A receptors and visual hallucinations in Parkinson disease.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:20385906" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a ParkinsonCanadaV1
| This area was generated with Dilib version V0.6.29. |  |